Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging.

Achilefu S, Dorshow RB, Bugaj JE, Rajagopalan R.

Invest Radiol. 2000 Aug;35(8):479-85.

PMID:
10946975
[PubMed - indexed for MEDLINE]
2.

Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform.

Bugaj JE, Achilefu S, Dorshow RB, Rajagopalan R.

J Biomed Opt. 2001 Apr;6(2):122-33.

PMID:
11375721
[PubMed - indexed for MEDLINE]
3.

Time-resolved fluorescence polarization dynamics and optical imaging of Cytate: a prostate cancer receptor-targeted contrast agent.

Pu Y, Wang WB, Das BB, Achilefu S, Alfano RR.

Appl Opt. 2008 May 1;47(13):2281-9.

PMID:
18449292
[PubMed - indexed for MEDLINE]
4.

Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands.

Becker A, Hessenius C, Licha K, Ebert B, Sukowski U, Semmler W, Wiedenmann B, Grötzinger C.

Nat Biotechnol. 2001 Apr;19(4):327-31.

PMID:
11283589
[PubMed - indexed for MEDLINE]
5.

Spectral polarization imaging of human prostate cancer tissue using a near-infrared receptor-targeted contrast agent.

Pu Y, Wang WB, Tang GC, Zeng F, Achilefu S, Vitenson JH, Sawczuk I, Peters S, Lombardo JM, Alfano RR.

Technol Cancer Res Treat. 2005 Aug;4(4):429-36.

PMID:
16029061
[PubMed - indexed for MEDLINE]
6.

Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.

Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, Sevick-Muraca EM, Li C.

Cancer Res. 2003 Nov 15;63(22):7870-5.

PMID:
14633715
[PubMed - indexed for MEDLINE]
Free Article
7.

In vivo measurement of vascular modulation in experimental tumors using a fluorescent contrast agent.

Valentini G, D'Andrea C, Ferrari R, Pifferi A, Cubeddu R, Martinelli M, Natoli C, Ubezio P, Giavazzi R.

Photochem Photobiol. 2008 Sep-Oct;84(5):1249-56. doi: 10.1111/j.1751-1097.2008.00352.x. Epub 2008 Apr 12.

PMID:
18422875
[PubMed - indexed for MEDLINE]
8.

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.

Chen X, Conti PS, Moats RA.

Cancer Res. 2004 Nov 1;64(21):8009-14.

PMID:
15520209
[PubMed - indexed for MEDLINE]
Free Article
9.

Cyanine dyes as contrast agents for near-infrared imaging in vivo: acute tolerance, pharmacokinetics, and fluorescence imaging.

Ebert B, Riefke B, Sukowski U, Licha K.

J Biomed Opt. 2011 Jun;16(6):066003. doi: 10.1117/1.3585678.

PMID:
21721804
[PubMed - indexed for MEDLINE]
10.

Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis.

Fischer T, Gemeinhardt I, Wagner S, Stieglitz DV, Schnorr J, Hermann KG, Ebert B, Petzelt D, Macdonald R, Licha K, Schirner M, Krenn V, Kamradt T, Taupitz M.

Acad Radiol. 2006 Jan;13(1):4-13.

PMID:
16399028
[PubMed - indexed for MEDLINE]
11.

Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: comparison with infrared imaging.

Miyashiro I, Miyoshi N, Hiratsuka M, Kishi K, Yamada T, Ohue M, Ohigashi H, Yano M, Ishikawa O, Imaoka S.

Ann Surg Oncol. 2008 Jun;15(6):1640-3. doi: 10.1245/s10434-008-9872-7. Epub 2008 Apr 1.

PMID:
18379850
[PubMed - indexed for MEDLINE]
12.

Near-infrared fluorescent dyes for enhanced contrast in optical mammography: phantom experiments.

Ebert B, Sukowski U, Grosenick D, Wabnitz H, Moesta KT, Licha K, Becker A, Semmler W, Schlag PM, Rinneberg H.

J Biomed Opt. 2001 Apr;6(2):134-40.

PMID:
11375722
[PubMed - indexed for MEDLINE]
13.

Development of high-sensitivity near-infrared fluorescence imaging device for early cancer detection.

Chen Y, Intes X, Chance B.

Biomed Instrum Technol. 2005 Jan-Feb;39(1):75-85.

PMID:
15742853
[PubMed - indexed for MEDLINE]
14.

Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes.

Licha K, Hessenius C, Becker A, Henklein P, Bauer M, Wisniewski S, Wiedenmann B, Semmler W.

Bioconjug Chem. 2001 Jan-Feb;12(1):44-50.

PMID:
11170364
[PubMed - indexed for MEDLINE]
15.

Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.

Bernard BF, Krenning E, Breeman WA, Visser TJ, Bakker WH, Srinivasan A, de Jong M.

Nucl Med Commun. 2000 Nov;21(11):1079-85.

PMID:
11192715
[PubMed - indexed for MEDLINE]
16.

Basic study of an agent for reinforcement of near-infrared fluorescence on tumor tissue.

Inayama K, Ito S, Muguruma N, Kusaka Y, Bando T, Tadatsu Y, Tadatsu M, Ii K, Shibamura S, Takesako K.

Dig Liver Dis. 2003 Feb;35(2):88-93.

PMID:
12747626
[PubMed - indexed for MEDLINE]
17.

Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.

Achilefu S, Jimenez HN, Dorshow RB, Bugaj JE, Webb EG, Wilhelm RR, Rajagopalan R, Johler J, Erion JL.

J Med Chem. 2002 May 9;45(10):2003-15.

PMID:
11985468
[PubMed - indexed for MEDLINE]
18.

Near-infrared fluorescence imaging of microcalcification in an animal model of breast cancer.

Lenkinski RE, Ahmed M, Zaheer A, Frangioni JV, Goldberg SN.

Acad Radiol. 2003 Oct;10(10):1159-64.

PMID:
14587634
[PubMed - indexed for MEDLINE]
19.

Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.

Moon WK, Lin Y, O'Loughlin T, Tang Y, Kim DE, Weissleder R, Tung CH.

Bioconjug Chem. 2003 May-Jun;14(3):539-45.

PMID:
12757377
[PubMed - indexed for MEDLINE]
20.

Synthesis of a novel L-methyl-methionine-ICG-Der-02 fluorescent probe for in vivo near infrared imaging of tumors.

Mahounga DM, Shan L, Jie C, Du C, Wan S, Gu Y.

Mol Imaging Biol. 2012 Dec;14(6):699-707. doi: 10.1007/s11307-012-0560-4.

PMID:
22552743
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk